Back to Oncology
Oncologyv2003Evidence-Based

Additional Nodal Metastasis Nomogram

Predicts probability of additional non-sentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy

Clinical Input Parameters

Range: 0 — 14
Range: 0 — 7
cm
Range: 0 — 9 cm
Clinical Assessment
Awaiting Parameters
probability
—%
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Additional Nodal Metastasis Nomogram is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within oncology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Linear predictor = β₀ + β₁(nuclear grade) + β₂(LVI) + β₃(multifocal) + β₄(ER status) + β₅(negative SLNs) + β₆(positive SLNs) + β₇(pathologic size) + β₈(detection method). Probability = exp(linear predictor) / (1 + exp(linear predictor))

Clinical Pearls & Practice Notes

  • This nomogram was developed and validated at Memorial Sloan Kettering Cancer Center
  • Applies to breast cancer patients with positive sentinel lymph node biopsy
  • Decision thresholds may vary by institution and should incorporate patient factors
  • Modern practice often considers axillary radiation as alternative to completion dissection

Evidence & Literature Citations

  1. Van Zee KJ, Manasseh DM, Bevilacqua JL, Boolbol SK, Fey JV, Tan LK, Borgen PI, Cody HS 3rd, Kattan MW. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol. 2003 Dec;10(10):1140-51.
  2. Specht MC, Kattan MW, Gonen M, Fey J, Van Zee KJ. Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram. Ann Surg Oncol. 2005 Aug;12(8):654-9.

Score Interpretation Ranges

Very Low Risk0 – 10 pts

Very low probability

Low Risk10 – 20 pts

Low probability

Moderate Risk20 – 50 pts

Moderate probability

High Risk50 – 100 pts

High probability

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.